#PCBCommunity |🧠 #CONNECTATherapeutics launches Phase II development of its #pediatric program #CTH120 for Fragile X Syndrome ( #FXS), a rare neurological disorder, under the #FRAXCURE project with the support of a €2.5 million grant from the prestigious #EIC Accelerator program. 🔬

👉 tuit.cat/lqwe7

CONNECTA Therapeutics Secures EIC Funding for CTH120 Pediatric Development in Fragile X Syndrome CONNECTA Therapeutics has announced the launch of its pediatric development program for CTH120, a groundbreaking treatment for Fragile X Syndrome, supported by a €2.5M EIC grant.

CONNECTA Therapeutics Secures EIC Funding for CTH120 Pediatric Development in Fragile X Syndrome #Spain #Barcelona #Fragile_X_Syndrome #CONNECTA_Therapeutics #CTH120